Analysis of LRRK2 functional domains in nondominant Parkinson disease

Neurology. 2005 Oct 25;65(8):1319-21. doi: 10.1212/01.wnl.0000180517.70572.37.

Abstract

A comprehensive sequence analysis of 29 exons that code for the functional domains of LRRK2 in 160 nondominant Parkinson disease (PD) patients was performed. Novel variant screening in a further 470 sporadic PD patients and 630 controls revealed two novel variants (R1067Q and IVS33 + 6 T>A), which are likely to be pathogenic in five patients. One patient presented initially with a typical essential tremor phenotype, expanding the phenotypic spectrum of LRRK2 mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Amino Acid Sequence / genetics
  • Amino Acid Substitution / genetics
  • DNA Mutational Analysis
  • Exons / genetics
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing
  • Genotype
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Parkinson Disease / ethnology
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism
  • Phenotype
  • Point Mutation / genetics
  • Protein Serine-Threonine Kinases / chemistry
  • Protein Serine-Threonine Kinases / genetics*
  • Protein Structure, Tertiary / genetics
  • Racial Groups
  • Sex Distribution

Substances

  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases